Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings
CSL employees. William West | AFP | Getty Images Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it announced the exit of Paul McKenzie as chief executive officer, and posted weak earnings for the first half of its fiscal year. Shares fell 17% to 151.3 Australian dollars, their lowest since … Read more